Subversive Substrates of Glutathione Reductases from Plasmodium falciparum-Infected Red Blood Cells as Antimalarial Agents

Apicomplexan Parasites: Molecular Approaches toward Targeted Drug Development

Volumn , Issue , 2011, Pages 375-396

  Davioud Charvet, Elisabeth ^a   Lanfranchi, Don Antoine ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883912633     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527633883.ch20     Document Type: Chapter

References (58)

1. Baunaure, F. and Langsley, G. (2005) Protein traffic in Plasmodium infected-red blood cells. Med. Sci., 21, 523-529.
2. Egan, T.J. (2008) Recent advances in understanding the mechanism of hemozoin (malaria pigment) formation. J. Inorg. Biochem., 102, 1288-1299.
3. Atamna, H., and Ginsburg, H. (1995) Heme degradation in the presence of glutathione. A proposed mechanism to account for the high levels of non-heme iron found in the membranes of hemoglobinopathic red blood cells. J. Biol. Chem., 270, 24876-24883.
4. Ginsburg, H., Famin, O., Zhang, J.,, and Krugliak, M. (1998) Inhibition of glutathione-dependent degradation of heme by chloroquine, and amodiaquine as a possible basis for their antimalarial mode of action. Biochem. Pharmacol., 56, 1305-1313.
5. Atamna, H., Krugliak, M., Shalmiev, G., Deharo, E., Pescarmona, G.,, and Ginsburg, H. (1996) Mode of antimalarial effect of methylene blue, and some of its analogues on Plasmodium falciparum in culture, and their inhibition of P. vinckei petteri, and P. yoelii nigeriensis in vivo. Biochem. Pharmacol., 51, 693-700.
6. Ncokazi, K.K., and Egan, T.J. (2005) A colorimetric high-throughput betahematin inhibition screening assay for use in the search for antimalarial compounds. Anal. Biochem., 338, 306-319.
7. Riscoe, M., Kelly, J.X.,, and Winter, R. (2005) Xanthones as antimalarial agents: discovery, mode of action,, and optimization. Curr. Med. Chem., 12, 2539-2549.
8. de Villiers, K.A., Marques, H.M.,, and Egan, T.J. (2008) The crystal structure of halofantrine-ferriprotoporphyrin IX, and the mechanism of action of arylmethanol antimalarials. J. Inorg. Biochem., 102, 1660-1667.
9. Weissbuch, I., and Leiserowitz, L. (2008) Interplay between malaria, crystalline hemozoin formation,, and antimalarial drug action, and design. Chem. Rev., 108, 4899-4914.
10. Asher, C., de Villiers, K.A.,, and Egan, T.J. (2009) Speciation of ferriprotoporphyrinIX in aqueous, and mixed aqueous solution is controlled by solvent identity, pH,, and salt concentration. Inorg. Chem., 48, 7994-8003.
11. Schirmer, R.H., Müller, J.G.,, and Krauth-Siegel, R.L. (1995) Disulfide reductase inhibitors as chemotherapeutic agents: the design of drugs for trypanosomiasis, and malaria. Angew. Chem. Int. Ed., 34, 141-154.
12. Krauth-Siegel, R.L., Bauer, H.,, and Schirmer, R.H. (2005) Dithiol proteins as guardians of the intracellular redox milieu in parasites: old, and new drug targets in trypanosomes, and malaria-causing plasmodia. Angew. Chem. Int. Ed., 44, 690-715.
13. Ginsburg, H., Atamna, H., Shalmiev, G., Kanaani, J.,, and Krugliak, M. (1996) Resistance of glucose-6-phosphate dehydrogenase deficiency to malaria: effects of fava bean hydroxypyrimidine glucosides on Plasmodium falciparum growth in culture, and on the phagocytosis of infected cells. Parasitology, 113, 7-18.
14. Zhang, Y.A., Hempelmann, E.,, and Schirmer, R.H. (1988) Glutathione reductase inhibitors as potential antimalarial drugs. Effects of nitrosoureas on Plasmodium falciparum in vitro. Biochem. Pharmacol., 37, 855-860.
15. Zhang, Y., König, I.,, and Schirmer, R.H. (1988) Glutathione reductase-deficient erythrocytes as host cells of malarial parasites. Biochem. Pharmacol., 37, 861-865.
16. Cappellini, M.D., and Fiorelli, G. (2008) Glucose-6-phosphate dehydrogenase deficiency. Lancet, 371, 64-74.
17. Cappadoro, M., Giribaldi, G., O'Brien, E., Turrini, F.,Mannu, F., Ulliers, D., Simula, G. et al. (1998) Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood, 92, 2527-2534.
18. Chevion, M., Navok, T., Glaser, G.,, and Mager, J. (1982) The chemistry of favisminducing compounds. The properties of isouramil, and divicine, and their reaction with glutathione. Eur. J. Biochem., 127, 405-409.
19. Clark, I.A., Cowden, W.B., Hunt, N.H., Maxwell, L.E.,, and Mackie, E.J. (1984) Activity of divicine in Plasmodium vinckeiinfected mice has implications for treatment of favism, and epidemiology of G-6-PD deficiency. Br. J. Haematol., 57, 479-487.
20. Färber, P.M., Arscott, L.D., Williams, C.H., Jr, Becker, K.,, and Schirmer, R.H. (1998) Recombinant Plasmodium falciparum glutathione reductase is inhibited by the antimalarial dye methylene blue. FEBS Lett., 422, 311-314.
21. Schirmer, M., Scheiwein, M., Gromer, S., Becker, K.,, and Schirmer, R.H. (1999) Disulfide reductases are destabilized by physiologic concentrations of NADPH, in (eds S. Ghisla, P.M., Kroneck, P., Macheroux, and H. Sund), Flavins, and Flavoproteins, Agency for Scientific Publications, Berlin, pp. 857-862.
22. Schirmer, R.H., Adler, H., Zappe, H.A., Gromer, S., Becker, K., Coulibaly, B.,, and Meissner, P. (2008) Disulfide reductases as drug targets: Methylene blue combination therapies for falciparum malaria in African children, in Flavins, and Flavoproteins (eds S. Frago, C., Gómez-Moreno, and M. Medina), Prensas Universitarias Zaragoza, pp. 481-486.
23. Davioud-Charvet, E.,Müller, T., Bauer, H.,, and Schirmer, H.,1,4-naphthoquinones as inhibitors of glutathione reductases, and antimalarial agents. European Patent EP 08290278.4 (26 March, 2008). PCT/ EP2009/053483 (25 March, 2009).
24. Kessl, J.J., Lange, B.B., Merbitz-Zahradnik, T., Zwicker, K., Hill, P., Meunier, B., Pálsdóttir, H. et al. (2003) Molecular basis for atovaquone binding to the cytochrome bc1 complex. J. Biol. Chem., 278, 31312-31318.
25. Fry, M., and Pudney, M. (1992) Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(40-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80). Biochem. Pharmacol., 43, 1545-1553.
26. Kessl, J.J., Moskalev, N.V., Gribble, G.W., Nasr, M.,Meshnick, S.R.,, and Trumpower, B.L. (2007) Parameters determining the relative efficacy of hydroxy-naphthoquinone inhibitors of the cytochrome bc1 complex. Biochim. Biophys. Acta, 1767, 319-326.
27. Looareesuwan, S., Viravan, C., Webster, H.K., Kyle, D.E., Hutchinson, D.B.,, and Canfield, C.J. (1996) Clinical studies of atovaquone, alone or in combination with other antimalarial drugs for treatment of acute uncomplicated malaria in Thailand. Am. J. Trop. Med. Hyg., 54, 62-66.
28. Jambou, R., Legrand, E., Niang, M., Khim, N., Lim, P., Volney, B., Ekala, M.T.,et al. (2005) Resistance of Plasmodium falciparum field isolates to in-vitro artemether, and point mutations of the SERCA-type PfATPase6. Lancet, 366, 1960-1963.
29. Noranate, N., Durand, R., Tall, A., Marrama, L., Spiegel, A., Sokhna, C., Pradines, B.,et al. (2007) Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use. PLoS ONE, 2, e139.
30. Buchholz, K., Schirmer, R.H., Eubel, J.K., Akoachère, M.B., Dandekar, T., Becker, K.,et al. (2008) Interactions of methylene blue with human disulfide reductases, and their orthologues from Plasmodium falciparum. Antimicrob. Agents Chemother., 52, 183-191.
31. Buchholz, K., Comini, M.A., Wissenbach, D., Schirmer, R.H., Krauth-Siegel, R.L.,, and Gromer, S. (2008) Cytotoxic interactions of methylene blue with trypanosomatid-specific disulfide reductases, and their dithiol products. Mol. Biochem. Parasitol., 160, 65-69.
32. Coulibaly, B., Zoungrana, A., Mockenhaupt, F.P., Schirmer, R.H., Klose, C., Mansmann, U., Meissner, P.,et al. (2009) Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial. PLoS ONE, 4, e5318.
33. Zoungrana, A., Coulibaly, B., Sié, A., Walter-Sack, I., Mockenhaupt, F.P., Kouyaté, B., Schirmer, R.H.,et al. (2008) Safety, and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. PLoS ONE, 3, e1630.
34. Salmon-Chemin, L., Lemaire, A., De Freitas, S., Deprez, B., Sergheraert, C.,, and Davioud-Charvet, E. (2000) Parallel synthesis of a library of 1,4-naphthoquinones, and automated screening of potential inhibitors of trypanothione reductase from Trypanosoma cruzi. Bioorg. Med. Chem. Lett., 10, 631-635.
35. Salmon-Chemin, L., Buisine, E., Yardley, V., Kohler, S., Debreu, M.A., Landry, V., Sergheraert, C.,et al. (2001) 2-, and 3-substituted-1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase, and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis, and correlation between redoxcycling activities, and in vitro cytotoxicity. J. Med. Chem, 44 548-565.
36. Iyanagi, T., and Yamazaki, I. (1970) Oneelectron-transfer reactions in biochemical systems V. Difference in the mechanism of quinone reduction by the NADH dehydrogenase, and the NAD(P)H dehydrogenase (DT-diaphorase). Biochim. Biophys. Acta, 216, 282-294.
37. Nakamura, M., and Yamazaki, I. (1972) One-electron-transfer reactions in biochemical systems. VI. Changes in electron-transfer mechanism of lipoamide dehydrogenase by modification of sulfhydryl groups. Biochim. Biophys. Acta, 267, 249-257.
38. Biot, C., Dessolin, J., Grellier, P.,, and Davioud-Charvet, E. (2003) Double-drug development against antioxidant enzymes from Plasmodium falciparum. Redox Report, 8, 280-283.
39. Krauth-Siegel, R.L.,, and Coombs, G.H. (1999) Enzymes of parasite thiol metabolism as drug targets. Parasitol. Today, 15, 404-409.
40. Biot, C., Bauer, H., Schirmer, R.H.,, and Davioud-Charvet, E. (2004) 5-Substituted tetrazoles as bioisosteres of carboxylic acids. Bioisosterism, and mechanistic studies on glutathione reductase inhibitors as antimalarials. J. Med. Chem., 47, 5972-5983.
41. Morin, C., Besset, T., Moutet, J.C., Fayolle, M., Brückner, M., Limosin, D., Becker, K.,and Davioud-Charvet, E. (2008) The azaanalogues of 1,4-naphthoquinones are potent substrates, and inhibitors of plasmodial thioredoxin, and glutathione reductases, and of human erythrocyte glutathione reductase. Org. Biomol. Chem., 6, 2731-2742.
42. Lopez-Shirley, K., Zhang, F., Gosser, D., Scott, M.,, and Meshnick, S.R. (1994) Antimalarial quinones: redox potential dependence of methemoglobin formation, and heme release in erythrocytes. J. Lab. Clin. Med., 123, 126-130.
43. Davioud-Charvet, E., Delarue, S., Biot, C., Schwöbel, B., Böhme, C.C., Müssigbrodt, A.,Maes, L.,et al. (2001) Aprodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline. J. Med. Chem., 44, 4268-4276.
44. Bauer, H., Fritz-Wolf, K., Winzer, A., Kühner, S., Little, S., Yardley, V., Vezin, H.,et al. (2006) A fluoro analogue of the menadione derivative 6-[20-(30-Methyl)-10,40-naphthoquinolyl]hexanoic acid is a suicide substrate of glutathione reductase. Crystal structure of the alkylated human enzyme. J. Am. Chem. Soc., 128, 10784-10794.
45. Friebolin, W., Jannack, B., Wenzel, N., Furrer, J., Oeser, T., Sanchez, C.P., Lanzer, M.,et al. (2008) Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum. J. Med. Chem., 51, 1260-1277.
46. Meierjohan, S., Walter, R.D.,, and Müller, S. (2002) Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive, and chloroquine-resistant Plasmodium falciparum. Biochem. J., 368, 761-768.
47. Ginsburg, H. (2002) A double-headed prodrug that overcomes chloroquine resistance. Trends Parasitol., 18, 103.
48. Bernadou, J., and Meunier, B. (2004) Biomimetic chemical catalysts in the oxidative activation of drugs. Adv. Synth. Catal., 346, 171-184.
49. Chavain, N., Davioud-Charvet, E., Trivelli, X., Mbeki, L., Rottmann, M., Brun, R.,, and Biot, C. (2009) Antimalarial activities of ferroquine conjugates with either glutathione reductase inhibitors or glutathione depletors via a hydrolyzable amide linker. Bioorg. Med. Chem., 17, 8048-8059.
50. Chavain, N., Vezin, H., Dive, D., Touati, N., Paul, J.F., Buisine, E.,, and Biot, C. (2008) Investigation of the redox behavior of ferroquine, a new antimalarial. Mol. Pharm., 5, 710-716.
51. Kutner, S., Ginsburg, H.,, and Cabantchik, Z.I. (1983) Permselectivity changes in malaria (Plasmodium falciparum) infected human red blood cell membranes. J. Cell. Physiol., 114, 245-251.
52. Ginsburg, H., Kutner, S., Krugliak, M.,, and Cabantchik, Z.I. (1985) Characterization of permeation pathways appearing in the host membrane of Plasmodium falciparum-infected red blood cells. Mol. Biochem. Parasitol., 14, 313-322.
53. Kutner, S., Breuer, W.V., Ginsburg, H., Aley, S.B.,, and Cabantchik, Z.I. (1985) Characterization of permeation pathways in the plasma membrane of human erythrocytes infected with early stages of Plasmodium falciparum: association with parasite development. J. Cell. Physiol., 125, 521-527.
54. Bouyer, G., Egée, S.,, and Thomas, S.L. (2007) Toward a unifying model of malaria-induced channel activity. Proc. Natl Acad. Sci. USA, 104, 11044-11049.
55. Staines, H.M., Alkhalil, A., Allen, R.J., De Jonge, H.R., Derbyshire, E., Egée, S., Ginsburg, H.,et al. (2007) Electrophysiological studies of malaria parasite-infected erythrocytes: current status. Int. J. Parasitol., 37, 475-482.
56. Hogg, T., Nagarajan, K., Herzberg, S., Chen, L., Shen, X., Jiang, H., Wecke, M.,et al. (2006) Structural, and functional characterization of Falcipain-2, a hemoglobinase from the malarial parasite Plasmodium falciparum. J. Biol. Chem., 281, 25425-25437.
57. Monti, D., Vodopivec, B., Basilico, N., Olliaro, P.,, and Taramelli, D. (1999) A novel endogenous antimalarial: Fe(II)-protoporphyrin IX alpha (heme) inhibits hematin polymerization to beta-hematin (malaria pigment), and killsmalaria parasites. Biochemistry, 38, 8858-8863.
58. Anstey, N.M., Hassanali, M.Y., Mlalasi, J., Manyenga, D.,, and Mwaikambo, E.D. (1996) Elevated levels of methaemoglobin in Tanzanian children with severe, and uncomplicated malaria. Trans. R. Soc. Trop. Med. Hyg., 90, 147-151.